- Home
- VANI vs USGOW Comparison
VANI vs USGOW Comparison
Compare VANI & USGOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- USGOW
- Stock Information
- Founded
- VANI 1998
- USGOW 2015
- Country
- VANI United States
- USGOW Canada
- Employees
- VANI N/A
- USGOW N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- USGOW Precious Metals
- Sector
- VANI Health Care
- USGOW Basic Materials
- Exchange
- VANI Nasdaq
- USGOW Nasdaq
- Market Cap
- VANI 68.1M
- USGOW N/A
- IPO Year
- VANI 2014
- USGOW N/A
- Fundamental
- Price
- VANI $1.26
- USGOW $0.94
- Analyst Decision
- VANI Strong Buy
- USGOW
- Analyst Count
- VANI 1
- USGOW 0
- Target Price
- VANI $4.00
- USGOW N/A
- AVG Volume (30 Days)
- VANI 66.4K
- USGOW 16.4K
- Earning Date
- VANI 05-13-2025
- USGOW 02-14-2025
- Dividend Yield
- VANI N/A
- USGOW N/A
- EPS Growth
- VANI N/A
- USGOW N/A
- EPS
- VANI N/A
- USGOW N/A
- Revenue
- VANI N/A
- USGOW N/A
- Revenue This Year
- VANI N/A
- USGOW N/A
- Revenue Next Year
- VANI N/A
- USGOW N/A
- P/E Ratio
- VANI N/A
- USGOW N/A
- Revenue Growth
- VANI N/A
- USGOW N/A
- 52 Week Low
- VANI $0.91
- USGOW $0.27
- 52 Week High
- VANI $2.09
- USGOW $2.80
- Technical
- Relative Strength Index (RSI)
- VANI 77.37
- USGOW N/A
- Support Level
- VANI $1.13
- USGOW N/A
- Resistance Level
- VANI $1.16
- USGOW N/A
- Average True Range (ATR)
- VANI 0.05
- USGOW 0.00
- MACD
- VANI 0.02
- USGOW 0.00
- Stochastic Oscillator
- VANI 92.86
- USGOW 0.00
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.